|
1
|
Saha S, Koley M, Ghosh S, Giri M, Das A
and Goenka R: Documentation of prescriptions and clinical outcomes
in a homeopathic hospital setting in West Bengal, India. J Evid
Based Complementary Altern Med. 20:180–185. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Schwartz B, Harrison LH, Motter JS, Motter
RN, Hightower AW and Broome CV: Investigation of an outbreak of
Moraxella conjunctivitis at a Navajo boarding school. Am J
Ophthalmol. 107:341–347. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen Y, Zhang X, Yang L, Li M, Li B, Wang
W and Sheng M: Decreased PPAR-γ expression in the conjunctiva and
increased expression of TNF-α and IL-1β in the conjunctiva and tear
fluid of dry eye mice. Mol Med Rep. 9:2015–2023. 2014.PubMed/NCBI
|
|
4
|
Barisani-Asenbauer T, Inic-Kanada A, Belij
S, Marinkovic E, Stojicevic I, Montanaro J, Stein E, Bintner N and
Stojanovic M: The ocular conjunctiva as a mucosal immunization
route: A profile of the immune response to the model antigen
tetanus toxoid. PLoS One. 8:e606822013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Koulikovska M, van der Ploeg I, Herrmann B
and Montan PG: Respiratory syncytial virus and chlamydia are not
detectable by PCR in ongoing vernal keratoconjunctivitis. Ocul
Immunol Inflamm. 9:253–257. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Grayston JT, Woolridge RL, Chen CW, Assaad
FA, Maffei S, Yen CH and Yang CY: Bacterial conjunctivitis caused
by a base eye ointment used as a placebo. Rep U S Nav Med Res Lab.
4:1–11. 1960.
|
|
7
|
Doughty MJ: Sodium cromoglycate ophthalmic
solution as a Pharmacy Medicine for the management of
mild-to-moderate, non-infectious inflammation of the conjunctiva in
adults. Ophthalmic Physiol Opt. 16(Suppl 2): S33–S38. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Buckley P and Lowman DM: Chronic
non-infective conjunctivitis in rabbits. Lab Anim. 13:69–73. 1979.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nell B, Walde I, Billich A, Vit P and
Meingassner JG: The effect of topical pimecrolimus on
keratoconjunctivitis sicca and chronic superficial keratitis in
dogs: Results from an exploratory study. Vet Ophthalmol. 8:39–46.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ferreri AJ, Dolcetti R, Du MQ, Doglioni C,
Resti AG, Politi LS, De Conciliis C, Radford J, Bertoni F, Zucca E,
et al: Ocular adnexal MALT lymphoma: An intriguing model for
antigen-driven lymphomagenesis and microbial-targeted therapy. Ann
Oncol. 19:835–846. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen J, Huang C, Zhang B, Huang Q, Chen J
and Xu L: The effects of carvedilol on cardiac structural
remodeling: The role of endogenous nitric oxide in the activity of
carvedilol. Mol Med Rep. 7:1155–1158. 2013.PubMed/NCBI
|
|
12
|
Ronsein GE, Guidi DB, Benassi JC, Filho DW
and Pedrosa RC and Pedrosa RC: Cytoprotective effects of carvedilol
against oxygen free radical generation in rat liver. Redox Rep.
10:131–137. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Merayo-Lloves J, Zhao TZ, Dutt JE and
Foster CS: A new murine model of allergic conjunctivitis and
effectiveness of nedocromil sodium. J Allergy Clin Immunol.
97:1129–1140. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gong L, Sun X, Qu J, Wang L, Zhang M,
Zhang H, Wang L, Gu Y, Elion-Mboussa A, Roy L and Zhu B:
Loteprednol etabonate suspension 0.2% administered QID compared
with olopatadine solution 0.1% administered BID in the treatment of
seasonal allergic conjunctivitis: A multicenter, randomized,
investigator-masked, parallel group study in Chinese patients. Clin
Ther. 34:1259–1272. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chansaenroj J, Vongpunsawad S, Puenpa J,
Theamboonlers A, Vuthitanachot V, Chattakul P, Areechokchai D and
Poovorawan Y: Epidemic outbreak of acute haemorrhagic
conjunctivitis caused by coxsackievirus A24 in Thailand, 2014.
Epidemiol Infect. 143:3087–3093. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chang CJ, Yang HH, Chang CA and Tsai HY:
Relationship between air pollution and outpatient visits for
nonspecific conjunctivitis. Invest Ophthalmol Vis Sci. 53:429–433.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yasin MN, Hussain S, Malik F, Hameed A,
Sultan T, Qureshi F, Riaz H, Perveen G and Wajid A: Preparation and
characterization of chloramphenicol niosomes and comparison with
chloramphenicol eye drops (0.5%w/v) in experimental conjunctivitis
in albino rabbits. Pak J Pharm Sci. 25:117–121. 2012.PubMed/NCBI
|
|
18
|
Tanaka J, Tanaka H, Mizuki N, Nomura E,
Ito N, Nomura N, Yamane M, Hida T, Goshima Y, Hatano H, et al:
Semaphorin 3A controls allergic and inflammatory responses in
experimental allergic conjunctivitis. Int J Ophthalmol. 8:1–10.
2015.PubMed/NCBI
|
|
19
|
Enríquez-de-Salamanca A, Calder V, Gao J,
Galatowicz G, García-Vázquez C, Fernández I, Stern ME, Diebold Y
and Calonge M: Cytokine responses by conjunctival epithelial cells:
An in vitro model of ocular inflammation. Cytokine. 44:160–167.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Leonardi A, Curnow SJ, Zhan H and Calder
VL: Multiple cytokines in human tear specimens in seasonal and
chronic allergic eye disease and in conjunctival fibroblast
cultures. Clin Exp Allergy. 36:777–784. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
de Araújo Júnior RF, Souza TO, de Medeiros
CA, de Souza LB, Freitas ML, de Lucena HF, do Socorro Costa Feitosa
Alves M and de Araújo AA: Carvedilol decrease IL-1β and TNF-α,
inhibits MMP-2, MMP-9, COX-2, and RANKL expression, and
up-regulates OPG in a rat model of periodontitis. PLoS One.
8:e663912013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Arab HH and El-Sawalhi MM: Carvedilol
alleviates adjuvant-induced arthritis and subcutaneous air pouch
edema: Modulation of oxidative stress and inflammatory mediators.
Toxicol Appl Pharmacol. 268:241–248. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Levi-Schaffer F, Micera A, Zamir E,
Mechoulam H, Puxeddu I, Piliponsky AM, Aloe L and Pe'er J: Nerve
growth factor and eosinophils in inflamed juvenile conjunctival
nevus. Invest Ophthalmol Vis Sci. 43:1850–1856. 2002.PubMed/NCBI
|
|
24
|
Lambiase A, Bonini S, Micera A, Rama P,
Bonini S and Aloe L: Expression of nerve growth factor receptors on
the ocular surface in healthy subjects and during manifestation of
inflammatory diseases. Invest Ophthalmol Vis Sci. 39:1272–1275.
1998.PubMed/NCBI
|
|
25
|
Kritas SK, Saggini A, Cerulli G, Caraffa
A, Antinolfi P, Pantalone A, Frydas S, Rosati M, Tei M, Speziali A,
et al: Neuropeptide NGF mediates neuro-immune response and
inflammation through mast cell activation. J Biol Regul Homeost
Agents. 28:177–181. 2014.PubMed/NCBI
|
|
26
|
Micera A, Stampachiacchiere B, Normando
EM, Lambiase A and Bonini S and Bonini S: Nerve growth factor
modulates toll-like receptor (TLR) 4 and 9 expression in cultured
primary VKC conjunctival epithelial cells. Mol Vis. 15:2037–2044.
2009.PubMed/NCBI
|
|
27
|
Shyu KG, Liou JY, Wang BW, Fang WJ and
Chang H: Carvedilol prevents cardiac hypertrophy and overexpression
of hypoxia-inducible factor-1alpha and vascular endothelial growth
factor in pressure-overloaded rat heart. J Biomed Sci. 12:409–420.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shyu KG, Lu MJ, Chang H, Sun HY, Wang BW
and Kuan P: Carvedilol modulates the expression of
hypoxia-inducible factor-1alpha and vascular endothelial growth
factor in a rat model of volume-overload heart failure. J Card
Fail. 11:152–159. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang F, Xu P, Xie KC, Chen XF, Li CY and
Huang Q: Effects of tumor microenviromental factors on VEGF
expression. Biomed Rep. 1:539–544. 2013.PubMed/NCBI
|
|
30
|
Taurone S, Ripandelli G, Pacella E,
Bianchi E, Plateroti AM, De Vito S, Plateroti P, Grippaudo FR,
Cavallotti C and Artico M: Potential regulatory molecules in the
human trabecular meshwork of patients with glaucoma:
Immunohistochemical profile of a number of inflammatory cytokines.
Mol Med Rep. 11:1384–1390. 2015.PubMed/NCBI
|
|
31
|
Goi T, Nakazawa T, Hirono Y and Yamaguchi
A: The anti-tumor effect is enhanced by simultaneously targeting
VEGF and PROK1 in colorectal cancer. Oncotarget. 8:6053–6061. 2015.
View Article : Google Scholar
|
|
32
|
de Boer RA, Siebelink HJ, Tio RA, Boomsma
F and van Veldhuisen DJ: Carvedilol increases plasma vascular
endothelial growth factor (VEGF) in patients with chronic heart
failure. Eur J Heart Fail. 3:331–333. 2001. View Article : Google Scholar : PubMed/NCBI
|
